Pathfinder Cell Therapy
(OTC) PFND
Pathfinder Cell Therapy Financials at a Glance
Market Cap
$700
Revenue (TTM)
$0.00
Net Income (TTM)
$1.39M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-3.30 (Low)
Dividend
$0.00
Beta (Volatility)
-3.30 (Low)
Price
$0.00
Volume
1,000
Open
$0.00
Price
$0.00
Volume
1,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
-3.30 (Low)
Price
$0.00
Volume
1,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
PFND News
PFND: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pathfinder Cell Therapy
PFND Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
19%
Return on Assets
-16%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$700.00
Shares Outstanding
667.16M
Volume
1.00K
Short Interest
0.00%
Avg. Volume
16.393
Financials (TTM)
Gross Profit
$0.00
Operating Income
$1.12M
EBITDA
$1.12M
Operating Cash Flow
$963.00K
Capital Expenditure
$0.00
Free Cash Flow
$963.00K
Cash & ST Invst.
$26.00K
Total Debt
$4.98M
Pathfinder Cell Therapy Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$700.00
N/A
Market Cap/Employee
$700.00
N/A
Employees
1
N/A
Net Income
$369.00K
-3.9%
EBITDA
$208.00K
+1.9%
Quarterly Fundamentals
Net Cash
$5.41M
-13.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$5.41M
+12.7%
Return on Assets
-15.75%
N/A
Return on Invested Capital
18.83%
N/A
Free Cash Flow
$178.00K
+21.9%
Operating Cash Flow
$178.00K
+21.9%